Le Lézard
Classified in: Health, Science and technology, Business
Subjects: LIC, VEN

Verana Health Selects Chasm Partners to Help Spearhead Company Growth and Scale Management Team


NEW YORK, Aug. 2, 2018 /PRNewswire/ -- Today Chasm Partners announced that it has been retained to help build out the management team of Verana Health, the developer of a cutting-edge specialty data platform for healthcare, which just announced its Series C funding. Chasm Partners, a retained executive search firm specializing in healthcare technology and services, is leading multiple executive-level commercial and operational searches for Verana Health's San Francisco and New York City offices.

Chasm Partners is a retained search firm focused on placing top talent in high-growth venture backed companies. We specialize in helping organizations scale in highly disruptive sectors facing transformation including Healthcare Technology & Services, Big Data & Analytics and Enterprise Software. In addition to retained search, Chasm invests in many of its clients and provides additional services to help them scale and grow. For more information, visit www.chasmpartners.com. (PRNewsfoto/Amendola Communications)

The Verana platform utilizes regulatory-grade specialty data sets to accelerate life science innovation. This platform currently features real-world data from the world's largest specialty clinical database, representing billions of data points, to deeply understand patient needs and to optimize drug and device development from clinical research through to post-commercialization.

"We are delighted that Chasm has been chosen to help Verana Health achieve its full potential as the leading specialty platform for deep data insights in healthcare by combining real-world data and advanced analytics," said Matt Dumas, Managing Partner of Chasm Partners. "With our expertise in artificial intelligence and in the healthcare analytics space, and Verana's incredible promise, we're confident in our ability to build out an industry-leading management team to fuel the company's continued progress."

"Now that we've received our Series C funding, we are excited to partner with Chasm to rapidly build out our leadership team in San Francisco and New York City," said Miki Kapoor, Chief Executive Officer and President of Verana Health. "Chasm brings deep operating experience in the analytics space as well as an incredible track record in helping venture-backed companies like Verana quickly scale by leveraging their strong network of top talent."

About Chasm Partners
Chasm Partners is a retained search firm focused on placing top talent in high-growth venture backed companies. We specialize in helping organizations scale in highly disruptive sectors facing transformation including Healthcare Technology & Services, Big Data & Analytics and Enterprise Software. In addition to retained search, Chasm invests in many of its clients and provides additional services to help them scale and grow including recruitment process outsourcing and leadership development.  For more information, visit www.chasmpartners.com.

Media Contact: Lisa Chernikoff, Amendola Communications for Chasm Partners, 734-678-5513, [email protected]

 

SOURCE Chasm Partners


These press releases may also interest you

at 18:50
Getting specialty medications into...

at 18:30
Arthrex, a global leader in minimally invasive surgical technology, has once again taken home prestigious medals for product innovation at the 37th annual Edison Awards. "This product, along with our other innovations,...

at 18:23
Aligned with the trend of immersive water therapy in 2024, Baros Maldives' Serenity Spa stands out as an oasis of indulgent spa and beauty rituals, boasting a 50-year legacy of luxury. Nestled within a tranquil sanctuary amidst the lush Maldivian...

at 17:55
Oragenics, Inc. , a company focused on developing unique, intranasal pharmaceuticals for the treatment of neurological disorders, today announced that it received a notice (the "Notice") from the NYSE American LLC (the "NYSE American") dated April...

at 17:20
Building on a successful phase one in which STChealth proved that the Universal Patient Identifier (UPI)?powered by Experian Health's Universal Identity Manager (UIM) and NCPDP Standardstm?can accurately identify patients across multiple datasets in...

at 17:00
StateHouse Holdings Inc. ("StateHouse" or the "Company") , a California-focused, vertically integrated cannabis company, today announced further to its press release dated April 15, 2024, that the Ontario Securities Commission (the "OSC") has denied...



News published on and distributed by: